Log In
BCIQ
Print this Print this
 

CEP-11981

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionVascular endothelial growth factor (VEGF) and Tie2 kinase inhibitor
Molecular Target Tyrosine kinase receptor 2 (Tie2) ; Vascular endothelial growth factor (VEGF)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor; Tyrosine kinase receptor 2 (Tie2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today